Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2(+):ERα(-) breast cancer

por Liu, Jeffrey C., Zacksenhouse, Miriam, Eisen, Andrea, Nofech-Mozes, Sharon, Zacksenhaus, Eldad
Publicado 2017

Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer—A Literature Review

por Mata, Danilo Giffoni de Mello Morais, Amir Carmona, Carlos, Eisen, Andrea, Trudeau, Maureen
Publicado 2022

Patient opinions on contralateral prophylactic mastectomy: A patient-driven discussion in need of tuning?

por Brown, Zachary M., Schellenberg, Angela E., Cordeiro, Erin, Holloway, Claire M.B., Scheer, Adena S., Eisen, Andrea
Publicado 2022

Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

por Blanchette, Phillip, Sivajohanathan, Duvaraga, Bartlett, John, Eisen, Andrea, Feilotter, Harriet, Pezo, Rossanna, Turashvili, Gulisa, Williams, Phillip
Publicado 2022

Preoperative Breast Magnetic Resonance Imaging: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

por Muradali, Derek, Fletcher, Glenn G., Cordeiro, Erin, Fienberg, Samantha, George, Ralph, Kulkarni, Supriya, Seely, Jean M., Shaheen, Rola, Eisen, Andrea
Publicado 2023

Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’

por Kotsopoulos, Joanne, Metcalfe, Kelly, Alston, Jill, Nikitina, Dina, Ginsburg, Ophira, Eisen, Andrea, Demsky, Rochelle, Akbari, Mohammad, Zbuk, Kevin, Narod, Steven A
Publicado 2014

Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program

por Eisen, Andrea, Blackmore, Kristina M., Meschino, Wendy S., Muradali, Derek, Carroll, June C., Majpruz, Vicky, Warner, Ellen, Rabeneck, Linda, Chiarelli, Anna M.
Publicado 2018

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol

por Dossa, Fahima, Cusimano, Maria C, Sutradhar, Rinku, Metcalfe, Kelly, Little, Tari, Lerner-Ellis, Jordan, Eisen, Andrea, Meschino, Wendy S, Baxter, Nancy N
Publicado 2018

Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation

por Holloway, Claire M. B., Shabestari, Omid, Eberg, Maria, Forster, Katharina, Murray, Paula, Green, Bo, Esensoy, Ali Vahit, Eisen, Andrea, Sussman, Jonathan
Publicado 2022

Determining the Cancer Diagnostic Interval Using Administrative Health Care Data in a Breast Cancer Cohort

por Groome, Patti A., Webber, Colleen, Whitehead, Marlo, Moineddin, Rahim, Grunfeld, Eva, Eisen, Andrea, Gilbert, Julie, Holloway, Claire, Irish, Jonathan C., Langley, Hugh
Publicado 2019

Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis

por Dossa, Fahima, Metcalfe, Kelly, Sutradhar, Rinku, Little, Tari, Eisen, Andrea, Chun, Kathy, Meschino, Wendy S., Velsher, Lea, Ellis, Jordan Lerner, Baxter, Nancy N.
Publicado 2021

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study

por Iqbal, Javaid, Nussenzweig, Andre, Lubinski, Jan, Byrski, Tomasz, Eisen, Andrea, Bordeleau, Louise, Tung, Nadine M, Manoukian, Siranoush, Phelan, Catherine M, Sun, Ping, Narod, Steven A
Publicado 2016

Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study

por Habbous, Steven, Homenauth, Esha, Barisic, Andriana, Kandasamy, Sharmilaa, Majpruz, Vicky, Forster, Katharina, Yurcan, Marta, Chiarelli, Anna M., Groome, Patti, Holloway, Claire M.B., Eisen, Andrea
Publicado 2022

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

por Byrski, Tomasz, Dent, Rebecca, Blecharz, Pawel, Foszczynska-Kloda, Malgorzata, Gronwald, Jacek, Huzarski, Tomasz, Cybulski, Cezary, Marczyk, Elzbieta, Chrzan, Robert, Eisen, Andrea, Lubinski, Jan, Narod, Steven A
Publicado 2012

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis

por Metcalfe, Kelly, Gershman, Shelley, Ghadirian, Parviz, Lynch, Henry T, Snyder, Carrie, Tung, Nadine, Kim-Sing, Charmaine, Eisen, Andrea, Foulkes, William D, Rosen, Barry, Sun, Ping, Narod, Steven A
Publicado 2014

Oestrogen receptor status and survival in women with BRCA2-associated breast cancer

por Metcalfe, Kelly, Lynch, Henry T., Foulkes, William D., Tung, Nadine, Olopade, Olufunmilayo I., Eisen, Andrea, Lerner-Ellis, Jordan, Snyder, Carrie, Kim, Shana J., Sun, Ping, Narod, Steven A.
Publicado 2019

Predictors of mammographic density among women with a strong family history of breast cancer

por Moran, Olivia, Eisen, Andrea, Demsky, Rochelle, Blackmore, Kristina, Knight, Julia A., Panchal, Seema, Ginsburg, Ophira, Zbuk, Kevin, Yaffe, Martin, Metcalfe, Kelly A., Narod, Steven A., Kotsopoulos, Joanne
Publicado 2019

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

por Kotsopoulos, Joanne, Olopado, Olufunmilayo I, Ghadirian, Parviz, Lubinski, Jan, Lynch, Henry T, Isaacs, Claudine, Weber, Barbara, Kim-Sing, Charmaine, Ainsworth, Peter, Foulkes, William D, Eisen, Andrea, Sun, Ping, Narod, Steven A
Publicado 2005

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

por Metcalfe, Kelly A, Foulkes, William D, Lynch, Henry T, Ghadirian, Parviz, Tung, Nadine, Olivotto, Ivo A, Warner, Ellen, Olopade, Olufunmilayo, Eisen, Andrea, Weber, Barbara, McLennan, Jane, Sun, Ping, Narod, Steven A
Publicado 2005

Early Changes in Quantitative Ultrasound Imaging Parameters during Neoadjuvant Chemotherapy to Predict Recurrence in Patients with Locally Advanced Breast Cancer

por Bhardwaj, Divya, Dasgupta, Archya, DiCenzo, Daniel, Brade, Stephen, Fatima, Kashuf, Quiaoit, Karina, Trudeau, Maureen, Gandhi, Sonal, Eisen, Andrea, Wright, Frances, Look-Hong, Nicole, Curpen, Belinda, Sannachi, Lakshmanan, Czarnota, Gregory J.
Publicado 2022